IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today FDA clearance of the Rad-G™ Pulse Oximeter, a rugged handheld device that provides clinically proven SET ® pulse oximetry, ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today FDA clearance of MightySat ® Medical, making it the first and only FDA-cleared medical fingertip pulse oximeter available ...

Masimo Corporation MASI recently announced the FDA clearance of its Masimo SET-powered MightySat Medical Pulse Oximeter, available Over-The-Counter (OTC) to consumers without a prescription. This ...

About a week after the FDA convened its latest meeting to discuss strategies for reducing racial biases in widely available pulse oximetry technology, Masimo has released new study data suggesting ...

Masimo has announced the limited market release of Spot-Check Rad-67™ Handheld Pulse CO-Oximeter®. While Rad-67 is not yet available for sale in the United States, in Europe providers can consider the ...

This morning medical device company Masimo announced FDA clearance for the measurement of respiration rate from a photoplethysmogram (RRp), so that it may now be used on the MightSat Rx finger pulse ...

Dublin, Nov. 25, 2020 (GLOBE NEWSWIRE) -- The "Pulse Oximeters Market Size, Share & Trends Analysis Report by Type (Fingertip, Handheld), by End Use (Hospitals & Healthcare Facilities, Homecare), by ...

Feb 16 (Reuters) - Life sciences firm Danaher is closing in on a nearly $10 billion deal to acquire pulse oximeter maker ...

Dublin, Sept. 30, 2020 (GLOBE NEWSWIRE) -- The "Pulse Oximeter Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The pulse oximeter market by ...

Joe Kiani, Founder and CEO of Masimo, said, “Until now, consumers and even healthcare providers had no way of knowing what pulse oximeter they could trust to use at home. On the internet and even in ...